Journal of Cardiac Failure

Papers
(The H4-Index of Journal of Cardiac Failure is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Universal Definition and Classification of Heart Failure345
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms221
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure150
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19141
Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America133
Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic82
Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes74
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure61
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis58
Sex Differences in Heart Failure56
Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors52
The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure48
Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial47
Heart Failure-Related Cardiogenic Shock: Pathophysiology, Evaluation and Management Considerations46
Metabolomic Profile in HFpEF vs HFrEF Patients45
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary43
Economic Issues in Heart Failure in the United States41
Trends in Heart Failure Hospitalizations in the US from 2008 to 201840
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry39
Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series37
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America36
Racial and Ethnic Disparities Persist in the Current Era of Pediatric Heart Transplantation35
Myocardial Ketones Metabolism in Heart Failure35
Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock33
Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review32
Vagus Nerve Stimulation Provides Multiyear Improvements in Autonomic Function and Cardiac Electrical Stability in the ANTHEM-HF Study32
Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure31
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review30
Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study30
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience29
The Effect of Decongestion on Intrarenal Venous Flow Patterns in Patients With Acute Heart Failure29
0.10627698898315